Wall Street brokerages predict that Mazor Robotics Ltd. (NASDAQ:MZOR) will report earnings of ($0.25) per share for the current fiscal quarter, according to Zacks. Zero analysts have provided estimates for Mazor Robotics’ earnings. The highest EPS estimate is ($0.24) and the lowest is ($0.26). Mazor Robotics reported earnings of ($0.19) per share in the same quarter last year, which indicates a negative year-over-year growth rate of 31.6%. The business is scheduled to report its next quarterly earnings report before the market opens on Tuesday, August 1st.
According to Zacks, analysts expect that Mazor Robotics will report full year earnings of ($0.89) per share for the current financial year, with EPS estimates ranging from ($0.94) to ($0.80). For the next financial year, analysts expect that the firm will post earnings of ($0.54) per share, with EPS estimates ranging from ($0.68) to ($0.20). Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side research firms that follow Mazor Robotics.
Mazor Robotics (NASDAQ:MZOR) last released its earnings results on Wednesday, May 10th. The medical instruments supplier reported ($0.22) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.20) by $0.02. The firm had revenue of $11.70 million during the quarter, compared to analysts’ expectations of $11.49 million. Mazor Robotics had a negative return on equity of 30.90% and a negative net margin of 45.08%. The firm’s revenue was up 82.8% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.10) earnings per share.
Several brokerages recently commented on MZOR. B. Riley restated a “neutral” rating and issued a $31.00 price target on shares of Mazor Robotics in a research report on Monday, May 15th. Needham & Company LLC restated a “hold” rating on shares of Mazor Robotics in a research report on Thursday. First Analysis downgraded shares of Mazor Robotics from an “overweight” rating to an “equal weight” rating and upped their price target for the company from $28.00 to $38.00 in a research report on Thursday, May 11th. ValuEngine upgraded shares of Mazor Robotics from a “sell” rating to a “hold” rating in a research report on Friday, June 2nd. Finally, Barclays PLC downgraded shares of Mazor Robotics from an “overweight” rating to an “equal weight” rating and upped their price target for the company from $31.00 to $32.00 in a research report on Monday, April 24th. They noted that the move was a valuation call. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and one has assigned a buy rating to the company. Mazor Robotics presently has a consensus rating of “Hold” and an average target price of $33.50.
ILLEGAL ACTIVITY NOTICE: “-$0.25 Earnings Per Share Expected for Mazor Robotics Ltd. (MZOR) This Quarter” was published by WKRB News and is the property of of WKRB News. If you are accessing this article on another website, it was illegally copied and republished in violation of United States and international trademark and copyright law. The correct version of this article can be accessed at https://www.wkrb13.com/markets/2286193/0-25-earnings-per-share-expected-for-mazor-robotics-ltd-mzor-this-quarter.html.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in MZOR. OppenheimerFunds Inc. raised its position in Mazor Robotics by 21.0% in the first quarter. OppenheimerFunds Inc. now owns 915,780 shares of the medical instruments supplier’s stock valued at $27,263,000 after buying an additional 158,690 shares in the last quarter. Credit Suisse AG raised its position in Mazor Robotics by 66.5% in the first quarter. Credit Suisse AG now owns 330,000 shares of the medical instruments supplier’s stock valued at $9,824,000 after buying an additional 131,804 shares in the last quarter. Menora Mivtachim Holdings LTD. raised its position in Mazor Robotics by 57.2% in the first quarter. Menora Mivtachim Holdings LTD. now owns 235,867 shares of the medical instruments supplier’s stock valued at $7,022,000 after buying an additional 85,867 shares in the last quarter. Candriam Luxembourg S.C.A. raised its position in Mazor Robotics by 26.7% in the first quarter. Candriam Luxembourg S.C.A. now owns 186,167 shares of the medical instruments supplier’s stock valued at $5,542,000 after buying an additional 39,232 shares in the last quarter. Finally, Credit Agricole S A bought a new position in Mazor Robotics during the first quarter valued at $3,929,000. Hedge funds and other institutional investors own 26.89% of the company’s stock.
Shares of Mazor Robotics (NASDAQ:MZOR) traded up 5.33% during mid-day trading on Monday, hitting $40.88. 563,207 shares of the stock traded hands. The company’s market cap is $976.01 million. The stock has a 50-day moving average of $37.52 and a 200-day moving average of $28.88. Mazor Robotics has a 52 week low of $19.20 and a 52 week high of $45.64.
About Mazor Robotics
Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2286193/0-25-earnings-per-share-expected-for-mazor-robotics-ltd-mzor-this-quarter.html
Receive News & Ratings for Mazor Robotics Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.